Cargando…

Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls

BACKGROUND: Adenosine stress T1-mapping on cardiovascular magnetic resonance (CMR) can differentiate between normal, ischemic, infarcted, and remote myocardial tissue classes without the need for contrast agents. Regadenoson, a selective coronary vasodilator, is often used in stress perfusion imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Burrage, Matthew K., Shanmuganathan, Mayooran, Masi, Ambra, Hann, Evan, Zhang, Qiang, Popescu, Iulia A., Soundarajan, Rajkumar, Leal Pelado, Joana, Chow, Kelvin, Neubauer, Stefan, Piechnik, Stefan K., Ferreira, Vanessa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117972/
https://www.ncbi.nlm.nih.gov/pubmed/33705843
http://dx.doi.org/10.1016/j.ijcard.2021.03.010
_version_ 1783691669534670848
author Burrage, Matthew K.
Shanmuganathan, Mayooran
Masi, Ambra
Hann, Evan
Zhang, Qiang
Popescu, Iulia A.
Soundarajan, Rajkumar
Leal Pelado, Joana
Chow, Kelvin
Neubauer, Stefan
Piechnik, Stefan K.
Ferreira, Vanessa M.
author_facet Burrage, Matthew K.
Shanmuganathan, Mayooran
Masi, Ambra
Hann, Evan
Zhang, Qiang
Popescu, Iulia A.
Soundarajan, Rajkumar
Leal Pelado, Joana
Chow, Kelvin
Neubauer, Stefan
Piechnik, Stefan K.
Ferreira, Vanessa M.
author_sort Burrage, Matthew K.
collection PubMed
description BACKGROUND: Adenosine stress T1-mapping on cardiovascular magnetic resonance (CMR) can differentiate between normal, ischemic, infarcted, and remote myocardial tissue classes without the need for contrast agents. Regadenoson, a selective coronary vasodilator, is often used in stress perfusion imaging when adenosine is contra-indicated, and has advantages in ease of administration, safety profile, and clinical workflow. We aimed to characterize the regadenoson stress T1-mapping response in healthy individuals, and to investigate its ability to differentiate between myocardial tissue classes in patients with coronary artery disease (CAD). METHODS: Eleven healthy controls and 25 patients with CAD underwent regadenoson stress perfusion CMR, as well as rest and stress ShMOLLI T1-mapping. Native T1 values and stress T1 reactivity were derived for normal myocardium in healthy controls and for different myocardial tissue classes in patients with CAD. RESULTS: Healthy controls had normal myocardial native T1 values at rest (931 ± 22 ms) with significant global regadenoson stress T1 reactivity (δT1 = 8.2 ± 0.8% relative to baseline; p < 0.0001). Infarcted myocardium had significantly higher resting T1 (1215 ± 115 ms) than ischemic, remote, and normal myocardium (all p < 0.0001) with an abolished stress T1 response (δT1 = −0.8% [IQR: −1.9–0.5]). Ischemic myocardium had elevated resting T1 compared to normal (964 ± 57 ms; p < 0.01) with an abolished stress T1 response (δT1 = 0.5 ± 1.6%). Remote myocardium in patients had comparable resting T1 to normal (949 ms [IQR: 915–973]; p = 0.06) with blunted stress reactivity (δT1 = 4.3% [IQR: 3.1–6.3]; p < 0.0001). CONCLUSIONS: Healthy controls demonstrate significant stress T1 reactivity during regadenoson stress. Regadenoson stress and rest T1-mapping is a viable alternative to adenosine and exercise for the assessment of CAD and can distinguish between normal, ischemic, infarcted, and remote myocardium.
format Online
Article
Text
id pubmed-8117972
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81179722021-06-15 Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls Burrage, Matthew K. Shanmuganathan, Mayooran Masi, Ambra Hann, Evan Zhang, Qiang Popescu, Iulia A. Soundarajan, Rajkumar Leal Pelado, Joana Chow, Kelvin Neubauer, Stefan Piechnik, Stefan K. Ferreira, Vanessa M. Int J Cardiol Article BACKGROUND: Adenosine stress T1-mapping on cardiovascular magnetic resonance (CMR) can differentiate between normal, ischemic, infarcted, and remote myocardial tissue classes without the need for contrast agents. Regadenoson, a selective coronary vasodilator, is often used in stress perfusion imaging when adenosine is contra-indicated, and has advantages in ease of administration, safety profile, and clinical workflow. We aimed to characterize the regadenoson stress T1-mapping response in healthy individuals, and to investigate its ability to differentiate between myocardial tissue classes in patients with coronary artery disease (CAD). METHODS: Eleven healthy controls and 25 patients with CAD underwent regadenoson stress perfusion CMR, as well as rest and stress ShMOLLI T1-mapping. Native T1 values and stress T1 reactivity were derived for normal myocardium in healthy controls and for different myocardial tissue classes in patients with CAD. RESULTS: Healthy controls had normal myocardial native T1 values at rest (931 ± 22 ms) with significant global regadenoson stress T1 reactivity (δT1 = 8.2 ± 0.8% relative to baseline; p < 0.0001). Infarcted myocardium had significantly higher resting T1 (1215 ± 115 ms) than ischemic, remote, and normal myocardium (all p < 0.0001) with an abolished stress T1 response (δT1 = −0.8% [IQR: −1.9–0.5]). Ischemic myocardium had elevated resting T1 compared to normal (964 ± 57 ms; p < 0.01) with an abolished stress T1 response (δT1 = 0.5 ± 1.6%). Remote myocardium in patients had comparable resting T1 to normal (949 ms [IQR: 915–973]; p = 0.06) with blunted stress reactivity (δT1 = 4.3% [IQR: 3.1–6.3]; p < 0.0001). CONCLUSIONS: Healthy controls demonstrate significant stress T1 reactivity during regadenoson stress. Regadenoson stress and rest T1-mapping is a viable alternative to adenosine and exercise for the assessment of CAD and can distinguish between normal, ischemic, infarcted, and remote myocardium. Elsevier 2021-06-15 /pmc/articles/PMC8117972/ /pubmed/33705843 http://dx.doi.org/10.1016/j.ijcard.2021.03.010 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Burrage, Matthew K.
Shanmuganathan, Mayooran
Masi, Ambra
Hann, Evan
Zhang, Qiang
Popescu, Iulia A.
Soundarajan, Rajkumar
Leal Pelado, Joana
Chow, Kelvin
Neubauer, Stefan
Piechnik, Stefan K.
Ferreira, Vanessa M.
Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
title Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
title_full Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
title_fullStr Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
title_full_unstemmed Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
title_short Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
title_sort cardiovascular magnetic resonance stress and rest t1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117972/
https://www.ncbi.nlm.nih.gov/pubmed/33705843
http://dx.doi.org/10.1016/j.ijcard.2021.03.010
work_keys_str_mv AT burragematthewk cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT shanmuganathanmayooran cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT masiambra cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT hannevan cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT zhangqiang cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT popescuiuliaa cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT soundarajanrajkumar cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT lealpeladojoana cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT chowkelvin cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT neubauerstefan cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT piechnikstefank cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols
AT ferreiravanessam cardiovascularmagneticresonancestressandrestt1mappingusingregadenosonfordetectionofischemicheartdiseasecomparedtohealthycontrols